Prediction of Systemic Thromboembolism and Bleeding in Atrial Fibrillation Patients With Factor Xa Inhibitor (Apixaban, Rivaroxaban) by Echocardiographic Parameters: Prospective Observational Study (AF-ECHO Study)

NCT06779695 · clinicaltrials.gov ↗
ACTIVE_NOT_RECRUITING
Status
2000
Enrollment
OTHER
Sponsor class

Conditions

Sponsor

Korea University Anam Hospital

Collaborators